Fig. 4 (abstract P376).
From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
VIPhyb+ anti-PD-1 increases CD8+ T cells in tumor
Fig. 4 (abstract P376). | Journal for ImmunoTherapy of Cancer